ACCORD News

ACCORD News

Single electronic submissions of the IRAS Form for studies led from Northern Ireland, Scotland and Wales

Update to IRAS, the Integrated Research Application System, will introduce a single, e-submission of IRAS Forms and associated documents.  

Grants with NHS involvement - use of SOECAT for Scottish sponsors

We are writing to draw your attention to a change in the way that NHS costs are reviewed during grant applications. This is being driven primarily by new ways of handling NHS Excess Treatment Costs (ETCs) in England, but will also affect Scottish organisations applying to UK funders. 

Status of Travel Insurance and Clinical Trials

The Association of British Insurers (ABI) have confirmed to the Health Research Authority that participation in clinical trials does not affect eligibility criteria for travel insurance and have now withdrawn their guidance document “Clinical research trials and insurance”.

Accord Update/Training Events 2019

Accord Update/Training Events 2019

Bursaries for patient and public involvement in research

ACCORD: Bursaries for patient and public involvement in research

MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others

MHRA suspends use of certain Gadolinium contrast agents (GdCAs), and restricts uses of others.

MHRA Recall of Gadolinium-containing contrast agents

A class 2 medicine recall – action within 48 hours – has now been issued by the MHRA for Magnevist (Bayer plc) and Omniscan Solution (GE Healthcare).

GDPR: Important Information For Your Clinical Research

The General Data Protection Regulation (GDPR) was implemented on 25 May 2018, together with a new Data Protection Act.

Changes to IRAS from 18 October 2017

Changes to IRAS from 18 October 2017

Changes to IRAS from 28 June 2017

Changes to IRAS - Effective June 28th 2017